Narrative review / 2013
Curcumin shows potential therapeutic efficacy and safety across multiple chronic diseases based on completed and ongoing clinical trials.
This review evaluates the pharmaceutical uses of curcumin, an active polyphenol found in turmeric. More than 65 human clinical trials including over 1,000 patients have been completed, with as many as 35 clinical trials underway. Preclinical and clinical research indicates curcumin targets multiple signaling pathways and chronic conditions, including cancer, cardiovascular, metabolic, pulmonary, neurological, autoimmune, and liver diseases.
- Study type
- Narrative review
- Who was studied
- More than 1,000 patients across over 65 completed human clinical trials
- What was measured
- Safety and therapeutic efficacy of curcumin in various chronic diseases
THE PAPER
Curcumin, a component of turmeric: from farm to pharmacy.
Gupta SC, Kismali G, Aggarwal BB. Biofactors, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.